JEFFREY BONNAUD: Open Payments
NPI 1275939332 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$111,891 in 317 payments from 21 companies in 2025. Trend: 2023 $69,889 · 2024 $85,330 · 2025 $111,891
Speaker / faculty: $71,167Consulting: $18,485Travel & lodging: $8,380Food & beverage: $8,037Honoraria: $5,775Education: $48
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 74 | $40,860 |
| Arcutis Biotherapeutics, Inc. | 44 | $21,385 |
| Janssen Biotech, Inc. | 31 | $16,462 |
| Lilly USA, LLC | 29 | $14,131 |
| ABBVIE INC. | 30 | $9,177 |
| Organon LLC | 19 | $7,694 |
| LEO Pharma Inc. | 14 | $395 |
| Incyte Corporation | 13 | $354 |
| Galderma Laboratories, L.P. | 16 | $350 |
| Novartis Pharmaceuticals Corporation | 9 | $224 |
Products named: Bimzelx, Zoryve, TREMFYA, EBGLYSS, VTAMA, SKYRIZI, RINVOQ, OPZELURA.
Industry payments across CA — which companies pay providers there.
